Laurianne Plastaras
Overview
Explore the profile of Laurianne Plastaras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amiel A, Van Gucht T, Bolliet M, Aussenac-Belle L, David P, Plastaras L, et al.
Am J Case Rep
. 2024 Dec;
25:e944829.
PMID: 39718979
BACKGROUND Hepatic lesion in a young woman can lead to multiple diagnostic hypotheses, mainly infection and tumor. Crohn's disease (CD) is hardly evoked by clinicians but is reportedly associated with...
2.
Amiot A, Seksik P, Meyer A, Stefanescu C, Wils P, Altwegg R, et al.
Gut
. 2024 Nov;
74(2):197-205.
PMID: 39586616
Background: It is unknown which maintenance therapy is the most effective option for patients admitted for an acute severe ulcerative colitis (ASUC) episode responding to intravenous steroids. Methods: We conducted...
3.
Amiot A, Chaibi S, Bouhnik Y, Serrero M, Filippi J, Roblin X, et al.
J Crohns Colitis
. 2023 Mar;
17(9):1418-1425.
PMID: 36988620
Background: Fatigue is commonly reported by patients with inflammatory bowel disease [IBD], but the determinants of IBD-related fatigue have yet to be determined. Aims: To identify the factors associated with...
4.
Buisson A, Serrero M, Orsat L, Nancey S, Riviere P, Altwegg R, et al.
Inflamm Bowel Dis
. 2022 Jul;
29(4):579-588.
PMID: 35815744
Background: Owing to growing number of therapeutic options with similar efficacy and safety, we compared the acceptability of therapeutic maintenance regimens in inflammatory bowel disease (IBD). Methods: From a nationwide...
5.
Boivineau G, Zallot C, Zerbib F, Plastaras L, Amiot A, Boivineau L, et al.
J Crohns Colitis
. 2022 Jul;
16(12):1816-1824.
PMID: 35793161
Background: Budesonide remains the backbone therapy for microscopic colitis [MC]; however, relapses are frequent, and some patients are intolerant or dependent. Anti-TNF therapy is increasingly used to treat these patients,...
6.
Amiot A, Seksik P, Reimund J, Nachury M, Altwegg R, Bourreille A, et al.
Dig Liver Dis
. 2022 May;
54(10):1350-1357.
PMID: 35577685
Background: The exact rate of contraindications to anti-TNF therapy and physician perspectives on treatment choices facing to anti-TNF contraindication, are poorly reported. Methods: A two-week cross-sectional study was conducted in...
7.
Letarouilly J, Pham T, Pierache A, Acquacalda E, Banneville B, Barbarot S, et al.
Rheumatology (Oxford)
. 2021 Nov;
61(7):2848-2855.
PMID: 34730790
Objectives: To describe new-onset IBD (new IBD) in patients treated with IL-17 inhibitors (IL-17i), to assess their incidence and to identify their risk factors in real life. Methods: A French...
8.
Tadbiri S, Nachury M, Bouhnik Y, Serrero M, Hebuterne X, Roblin X, et al.
J Crohns Colitis
. 2020 Nov;
15(5):766-773.
PMID: 33246337
Background And Aim: The inflammatory bowel disease [IBD]-disk is a 10-item self-questionnaire that is used to assess IBD-related disability. The aim of the present study was to evaluate this tool...
9.
Chapuis-Biron C, Kirchgesner J, Pariente B, Bouhnik Y, Amiot A, Viennot S, et al.
Am J Gastroenterol
. 2020 Nov;
115(11):1812-1820.
PMID: 33156100
Introduction: New therapeutic options for patients with Crohn's disease (CD) with perianal lesions failing anti-tumor necrosis factor (TNF) agents are needed. We aimed to assess the effectiveness of ustekinumab in...
10.
Lambin T, Amiot A, Stefanescu C, Gornet J, Seksik P, Laharie D, et al.
Dig Liver Dis
. 2020 Sep;
52(11):1323-1330.
PMID: 32962965
Background: There are few data concerning patients with Crohn's disease (CD) complicated by a stricture of the upper gastrointestinal tract (UGT). Aims: We evaluated the outcome and management of CD...